Mendillo Jane L
SEC insider (Form 3/4/5 filer). CIK 0001672424. Director at Generate Biomedicines, Inc. (GENB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SOMERVILLE, MA.
Companies Mendillo Jane L has filed insider reports for
- Generate Biomedicines, Inc. (GENB): Director
- Lazard, Inc. (LAZ): Director
Mendillo Jane L
CIK: 0001672424
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseDirect1.5K shares at avg. $16.00$24K - Feb 26, 2026GENB
Generate Biomedicines, Inc.
AwardDirectStock Option (Right to Buy)
29.6K shares- - Feb 18, 2025LAZ
Lazard, Inc.
AwardDirectDeferred Stock Units
642 shares- - Nov 15, 2024LAZ
Lazard, Inc.
AwardDirectDeferred Stock Units
636 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 |  GENB Generate Biomedicines, Inc. | Purchase | 1,500 | $16.00 | $24,000 | Direct |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | Award Stock Option (Right to Buy) | 29,561 | - | - | Direct |
| Feb 18, 2025 |  LAZ Lazard, Inc. | Award Deferred Stock Units | 642 | - | - | Direct |
| Nov 15, 2024 | LAZ Lazard, Inc. | Award Deferred Stock Units | 636 | - | - | Direct |
1-4 of 4 transactions